Your browser doesn't support javascript.
loading
Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.
Chery, Laura; Maki, Jennifer N; Mascarenhas, Anjali; Walke, Jayashri T; Gawas, Pooja; Almeida, Anvily; Fernandes, Mezia; Vaz, Marina; Ramanan, Rakesh; Shirodkar, Diksha; Bernabeu, Maria; Manoharan, Suresh Kumar; Pereira, Ligia; Dash, Rashmi; Sharma, Ambika; Shaik, Riaz Basha; Chakrabarti, Rimi; Babar, Prasad; White, John; Mudeppa, Devaraja G; Kumar, Shiva; Zuo, Wenyun; Skillman, Kristen M; Kanjee, Usheer; Lim, Caeul; Shaw-Saliba, Kathryn; Kumar, Ashwani; Valecha, Neena; Jindal, V N; Khandeparkar, Anar; Naik, Pradeep; Amonkar, Sunanda; Duraisingh, Manoj T; Tuljapurkar, Shripad; Smith, Joseph D; Dubhashi, Nagesh; Pinto, Roque G W; Silveria, Maria; Gomes, Edwin; Rathod, Pradipsinh K.
Afiliación
  • Chery L; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Maki JN; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Mascarenhas A; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Walke JT; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Gawas P; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Almeida A; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Fernandes M; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Vaz M; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Ramanan R; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Shirodkar D; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Bernabeu M; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Manoharan SK; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Pereira L; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Dash R; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Sharma A; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Shaik RB; Center for Infectious Disease Research (CIDR), Seattle, WA, 98109, USA.
  • Chakrabarti R; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Babar P; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • White J; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Mudeppa DG; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Kumar S; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Zuo W; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Skillman KM; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Kanjee U; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Lim C; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Shaw-Saliba K; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Kumar A; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Valecha N; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Jindal VN; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Khandeparkar A; Goa Medical College and Hospital, Bambolim, Goa, 403202, India.
  • Naik P; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Amonkar S; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Duraisingh MT; Departments of Chemistry and Global Health, University of Washington, Seattle, WA, 98195, USA.
  • Tuljapurkar S; Department of Biology, Stanford University, Stanford, CA, 94305, USA.
  • Smith JD; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Dubhashi N; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Pinto RG; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Silveria M; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Gomes E; National Institute of Malaria Research, Field Unit, Campal, Goa, 403001, India.
  • Rathod PK; National Institute of Malaria Research (ICMR), Sector 8, Dwarka, New Delhi, 110077, India.
Malar J ; 15(1): 569, 2016 11 25.
Article en En | MEDLINE | ID: mdl-27884146
ABSTRACT

BACKGROUND:

Malaria remains an important cause of morbidity and mortality in India. Though many comprehensive studies have been carried out in Africa and Southeast Asia to characterize and examine determinants of Plasmodium falciparum and Plasmodium vivax malaria pathogenesis, fewer have been conducted in India.

METHODS:

A prospective study of malaria-positive individuals was conducted at Goa Medical College and Hospital (GMC) from 2012 to 2015 to identify demographic, diagnostic and clinical indicators associated with P. falciparum and P. vivax infection on univariate analysis.

RESULTS:

Between 2012 and 2015, 74,571 febrile individuals, 6287 (8.4%) of whom were malaria positive, presented to GMC. The total number of malaria cases at GMC increased more than two-fold over four years, with both P. vivax and P. falciparum cases present year-round. Some 1116 malaria-positive individuals (mean age = 27, 91% male), 88.2% of whom were born outside of Goa and 51% of whom were construction workers, were enroled in the study. Of 1088 confirmed malaria-positive patients, 77.0% had P. vivax, 21.0% had P. falciparum and 2.0% had mixed malaria. Patients over 40 years of age and with P. falciparum infection were significantly (p < 0.001) more likely to be hospitalised than younger and P. vivax patients, respectively. While approximately equal percentages of hospitalised P. falciparum (76.6%) and P. vivax (78.9%) cases presented with at least one WHO severity indicator, a greater percentage of P. falciparum inpatients presented with at least two (43.9%, p < 0.05) and at least three (29.9%, p < 0.01) severity features. There were six deaths among the 182 hospitalised malaria positive patients, all of whom had P. falciparum.

CONCLUSION:

During the four year study period at GMC, the number of malaria cases increased substantially and the greatest burden of severe disease was contributed by P. falciparum.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria Vivax / Malaria Falciparum Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Malaria Vivax / Malaria Falciparum Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Malar J Asunto de la revista: MEDICINA TROPICAL Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos